How ALGN's Earnings Track Record Diverges From the Beat-Means-Bounce Narrative
Align Technology has delivered a strong headline beat rate over the last eight reported quarters: seven out of eight, or 88%, with an average earnings surprise of 5%. That consistency would normally suggest a bullish earnings history, but the post-earnings price behavior tells a different story. Across those same quarters, ALGN averaged a -2.2% return in the five trading days after the report, classified analytically as a "down" drift. In other words, even when the company topped estimates, the stock did not reliably hold or extend its initial reaction. The most recent four reports illustrate the split personality: on 2026-04-29, ALGN beat by 12.2% ($2.58 vs. $2.30) only to fall 1.34% the next day and 2.5% over the following five sessions. On 2026-02-04, a 10% beat ($3.29 vs. $2.99) produced an 8.88% next-day jump and a 22.45% five-day run. The 2025-10-29 quarter saw an 8.8% beat ($2.61 vs. $2.40) generate a 4.94% one-day gain that faded to 4.02% over five days. Only the 2025-07-30 miss (-3.1%, $2.49 vs. $2.57) triggered an extreme repricing: -36.63% the next day and -32.75% over five days. The asymmetry is stark—upside beats have produced lukewarm follow-through, while downside misses have been punished severely.
Reading the Tape Ahead of the July 29, 2026 Report
The next scheduled event is the 2026-07-29 after-close report, with the unofficial consensus EPS estimate at $2.62. As of the July 27, 2026 snapshot, ALGN traded at $167.015, below its 50-day EMA of $174.85 and with an RSI of 41.1 in the Healthcare/Medical - Devices sector. A 7/8 historical beat rate and 5% average surprise suggest the $2.62 bar is historically achievable, but the -2.2% average five-day post-earnings drift means the stock's post-report path has not rewarded simple directional expectations. In the options market, that headline-strength/price-weakness disconnect usually appears as elevated implied volatility ahead of the event and a sharp re-pricing of event premium afterward if the report does not reset the forward narrative. The wide historical spread—from the +22.45% surge after the February 2026 beat to the -36.63% collapse after the July 2025 miss—reinforces that ALGN's event risk is two-sided rather than purely directional.
What a Disciplined Trader Watches
With this dataset, the watchlist is less about predicting the result and more about reaction mechanics. Traders commonly monitor whether the opening move confirms or rejects the pre-event range, how volume compares with the prior report, and whether guidance language—not just the $2.62 EPS bar—drives the post-release repricing. The Healthcare/Medical - Devices sector context also matters: Invisalign demand, ASP trends, and scanner utilization can shift the multiple even when EPS lands above consensus. Because the average post-earnings drift is negative despite the high beat rate, a disciplined approach includes planning for post-event fade risk on gap-up opens and post-event continuation pressure on gap-down opens, while remembering that a single outlier quarter like the -36.63% July 2025 session can dominate any average. For a deeper dive into how institutional analysts, options positioning, and forward guidance are stacking up ahead of the 2026-07-29 print, see the full institutional verdict.
Frequently Asked Questions
How often has ALGN beaten earnings estimates?
Over the last eight reported quarters, ALGN beat earnings estimates seven times, for an 88% beat rate, with an average earnings surprise of 5%.
What was ALGN's biggest post-earnings decline in the recent data?
The largest drop came after the 2025-07-30 report, when ALGN missed with EPS of $2.49 versus the $2.57 estimate (-3.1% surprise) and the stock fell 36.63% the next day and 32.75% over the following five trading days.
When is ALGN's next earnings report and what is the consensus estimate?
ALGN's next scheduled report is on 2026-07-29 after the close, with the unofficial consensus EPS estimate at $2.62.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-04-29 | $2.58 | $2.3 | +12.2% | -1.34% | -2.5% |
| 2026-02-04 | $3.29 | $2.99 | +10% | +8.88% | +22.45% |
| 2025-10-29 | $2.61 | $2.4 | +8.8% | +4.94% | +4.02% |
| 2025-07-30 | $2.49 | $2.57 | -3.1% | -36.63% | -32.75% |
| 2025-04-30 | $2.13 | $1.99 | +7% | - | - |
| 2025-02-05 | $2.44 | $2.43 | +0.4% | - | - |
Previous ALGN editions
Get the institutional verdict on ALGN
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the ALGN verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.